List of works - J. Michael Kilby

A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).

scientific article published on 8 November 2006

Antibody neutralization and escape by HIV-1

scientific article (publication date: 20 March 2003)

CD8 T-cell proliferative capacity is compromised in primary HIV-1 infection.

scientific article published on March 2011

Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

scientific article

Corrigendum to “Modeling sequence evolution in acute HIV-1 infection” [J. Theor. Biol. 261 (2009) 341–360]

article

Cost-effectiveness of enfuvirtide in HIV therapy for treatment-experienced patients in the United States.

scientific article published on March 2006

Delayed access to HIV diagnosis and care: Special concerns for the Southern United States

scientific article published on January 2006

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

scientific article

Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic

scientific article published on May 2006

Functionally competent antigen-specific CD127(hi) memory CD8+ T cells are preserved only in HIV-infected individuals receiving early treatment

scientific article published on 20 November 2006

Gender differences in discontinuation of antiretroviral treatment regimens.

scientific article published in November 2009

HIV-1 and HAART: a time to cure, a time to kill

scientific article published on 01 June 1999

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

scientific article (publication date: 27 May 2008)

Images in clinical medicine. Cytomegalovirus esophageal ulcers

scientific article published on 01 February 2000

Novel therapies based on mechanisms of HIV-1 cell entry.

scientific article

Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis

scientific article

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

scientific article (publication date: November 1998)

Salmonella infections in the setting of AIDS: a serpentine course.

scientific article published in November 2005

Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection

scientific article

Stability in the HIV vDNA pool in peripheral CD4+ T cells of untreated patients by single tube quantitative PCR

scientific article published on 01 June 2000

Switching HIV therapies: competing host and viral factors

scientific article published on 12 January 2010

The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.

scientific article published in July 2002

The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections.

scientific article published on February 1998

List of works by J. Michael Kilby

A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).

Antibody neutralization and escape by HIV-1

CD8 T-cell proliferative capacity is compromised in primary HIV-1 infection.

Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

Corrigendum to “Modeling sequence evolution in acute HIV-1 infection” [J. Theor. Biol. 261 (2009) 341–360]

Cost-effectiveness of enfuvirtide in HIV therapy for treatment-experienced patients in the United States.

Delayed access to HIV diagnosis and care: Special concerns for the Southern United States

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic

Functionally competent antigen-specific CD127(hi) memory CD8+ T cells are preserved only in HIV-infected individuals receiving early treatment

Gender differences in discontinuation of antiretroviral treatment regimens.

HIV-1 and HAART: a time to cure, a time to kill

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Images in clinical medicine. Cytomegalovirus esophageal ulcers

Novel therapies based on mechanisms of HIV-1 cell entry.

Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

Salmonella infections in the setting of AIDS: a serpentine course.

Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection

Stability in the HIV vDNA pool in peripheral CD4+ T cells of untreated patients by single tube quantitative PCR

Switching HIV therapies: competing host and viral factors

The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.

The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections.